[18F]FDG Positron emission tomography with whole body magnetic resonance imaging ([18F]FDG-PET/MRI) as a diagnosis tool in Schwannomatosis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1750-1172
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
[18F]FDG Positron emission tomography with whole body magnetic resonance imaging ([18F]FDG-PET/MRI) as a diagnosis tool in Schwannomatosis ; volume:16 ; number:1 ; day:28 ; month:1 ; year:2021 ; pages:1-5 ; date:12.2021
Orphanet journal of rare diseases ; 16, Heft 1 (28.1.2021), 1-5, 12.2021
- Creator
-
Gallais Sérézal, I.
Ferkal, S.
Lerman, L.
Mulé, S.
Funalot, B.
Wolkenstein, P.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13023-021-01680-0
- URN
-
urn:nbn:de:101:1-2021032120211426255297
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Gallais Sérézal, I.
- Ferkal, S.
- Lerman, L.
- Mulé, S.
- Funalot, B.
- Wolkenstein, P.
- SpringerLink (Online service)
Other Objects (12)
Positron emission tomography in breast cancer: 18F- FDG and other radiopharmaceuticals
18F-FDG positron emission tomography/computed tomography of cardiac implantable electronic device infections
Dual time point 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in primary breast cancer
[18F]FDG and [18F]FLT positron emission tomography imaging following treatment with belinostat in human ovary cancer xenografts in mice
Role of 18F-FDG positron emission tomography in carotid atherosclerotic plaque imaging: A systematic review
18F-FDG positron emission tomography scanning in systemic sclerosis-associated interstitial lung disease: a pilot study
Assessment of tumor heterogeneity in treatment-naïve adrenocortical cancer patients using 18F-FDG positron emission tomography
In vivo molecular imaging of experimental joint inflammation by combined 18F-FDG positron emission tomography and computed tomography
Added value of regional 18F-FDG PET/MRI-assisted whole-body 18F-FDG PET/CT in malignant ascites with unknown primary origin
The use of 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) as a pathway-specific biomarker with AZD8186, a PI3Kβ/δ inhibitor
Whole-Body [18F]-FDG-PET/MRI for Oncology: A Consensus Recommendation
Patient-adapted organ absorbed dose and effective dose estimates in pediatric 18F-FDG positron emission tomography/computed tomography studies
Positron emission tomography in breast cancer: 18F- FDG and other radiopharmaceuticals
18F-FDG positron emission tomography/computed tomography of cardiac implantable electronic device infections
Dual time point 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in primary breast cancer
[18F]FDG and [18F]FLT positron emission tomography imaging following treatment with belinostat in human ovary cancer xenografts in mice
Role of 18F-FDG positron emission tomography in carotid atherosclerotic plaque imaging: A systematic review
18F-FDG positron emission tomography scanning in systemic sclerosis-associated interstitial lung disease: a pilot study
Assessment of tumor heterogeneity in treatment-naïve adrenocortical cancer patients using 18F-FDG positron emission tomography
In vivo molecular imaging of experimental joint inflammation by combined 18F-FDG positron emission tomography and computed tomography
Added value of regional 18F-FDG PET/MRI-assisted whole-body 18F-FDG PET/CT in malignant ascites with unknown primary origin
The use of 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) as a pathway-specific biomarker with AZD8186, a PI3Kβ/δ inhibitor
Whole-Body [18F]-FDG-PET/MRI for Oncology: A Consensus Recommendation
Patient-adapted organ absorbed dose and effective dose estimates in pediatric 18F-FDG positron emission tomography/computed tomography studies
Positron emission tomography in breast cancer: 18F- FDG and other radiopharmaceuticals
18F-FDG positron emission tomography/computed tomography of cardiac implantable electronic device infections
Dual time point 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in primary breast cancer
[18F]FDG and [18F]FLT positron emission tomography imaging following treatment with belinostat in human ovary cancer xenografts in mice
Role of 18F-FDG positron emission tomography in carotid atherosclerotic plaque imaging: A systematic review
18F-FDG positron emission tomography scanning in systemic sclerosis-associated interstitial lung disease: a pilot study
Assessment of tumor heterogeneity in treatment-naïve adrenocortical cancer patients using 18F-FDG positron emission tomography
In vivo molecular imaging of experimental joint inflammation by combined 18F-FDG positron emission tomography and computed tomography
Added value of regional 18F-FDG PET/MRI-assisted whole-body 18F-FDG PET/CT in malignant ascites with unknown primary origin
The use of 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) as a pathway-specific biomarker with AZD8186, a PI3Kβ/δ inhibitor
Whole-Body [18F]-FDG-PET/MRI for Oncology: A Consensus Recommendation